COVID Vaccination Information
Moderna & Pfizer Vaccines Available
All 7 of our locations are able to administer the initial series of either the Moderna, or the Pfizer vaccine at the time of your appointment with a medical provider, or on a vaccine clinic day. Call or text (304) 643-4005 to find clinic dates at the campus nearest you. RRHC Harrisville Campus' clinic day is every Wednesday 1 - 2 p.m.
We also offer the Pfizer vaccine to children ages 5 - 11, as well as the booster vaccines and additional doses for those that qualify.
The Booster Vaccine VS. The Additional Dose
Recent data shows some individuals may need a booster or an additional dose. The booster is meant for fully vaccinated individuals who have the appropriate level of immunity from the vaccine, but over time, has decreased.
The additional dose is for those who are immunocompromised and have received the initial series of Pfizer or Moderna vaccines. Eligible individuals include patients with cancer, organ and stem cell transplant recipients who take immune suppressant medication, those with an immunodeficiency, and anyone in active treatment taking medications that suppress an immune response. The additional dose can be administered as soon as 28 days following the second dose.
For more information about the booster vaccine, please visit:
wecandothis.hhs.gov/resource/frequently-asked-questions-about-covid-19-vaccine-boosters
The 2nd Booster Recommendation
As of March 29, 2022, after receiving their primary series shots and an initial (first) booster shot second booster shots of an mRNA COVID-19 vaccine (Pfizer or Moderna) are now recommended at least four months after the first booster shot for people who are:
All 7 of our locations are able to administer the initial series of either the Moderna, or the Pfizer vaccine at the time of your appointment with a medical provider, or on a vaccine clinic day. Call or text (304) 643-4005 to find clinic dates at the campus nearest you. RRHC Harrisville Campus' clinic day is every Wednesday 1 - 2 p.m.
We also offer the Pfizer vaccine to children ages 5 - 11, as well as the booster vaccines and additional doses for those that qualify.
The Booster Vaccine VS. The Additional Dose
Recent data shows some individuals may need a booster or an additional dose. The booster is meant for fully vaccinated individuals who have the appropriate level of immunity from the vaccine, but over time, has decreased.
The additional dose is for those who are immunocompromised and have received the initial series of Pfizer or Moderna vaccines. Eligible individuals include patients with cancer, organ and stem cell transplant recipients who take immune suppressant medication, those with an immunodeficiency, and anyone in active treatment taking medications that suppress an immune response. The additional dose can be administered as soon as 28 days following the second dose.
For more information about the booster vaccine, please visit:
wecandothis.hhs.gov/resource/frequently-asked-questions-about-covid-19-vaccine-boosters
The 2nd Booster Recommendation
As of March 29, 2022, after receiving their primary series shots and an initial (first) booster shot second booster shots of an mRNA COVID-19 vaccine (Pfizer or Moderna) are now recommended at least four months after the first booster shot for people who are:
- Ages 50+ who are 4 months or more from receiving their first booster shot, and
- Ages 12+ with serious and chronic health conditions that lead to being considered moderately to severely immunocompromised, as well as
- Ages 18-49 who are not immunocompromised and who received their primary series shot and their booster shot using the Johnson & Johnson COVID-19 vaccine for both
FDA Approves Expanded Use of Pfizer Booster Vaccine
On Monday, January 3, 2022 the Food and Drug Administration approved the following actions to expand the use of the Pfizer booster shots:
On Monday, January 3, 2022 the Food and Drug Administration approved the following actions to expand the use of the Pfizer booster shots:
- Expand the use of a single booster dose to include use in individuals 12 through 15 years of age
- Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months
- Allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age
CDC Endorses ACIP Recommendation
The CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
Data show that COVID-19 boosters help broaden and strengthen protection against Omicron and other SARS-CoV-2 variants. ACIP reviewed the available safety data following the administration of over 25 million vaccine doses in adolescents.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-17.
The CDC is endorsing the Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series.
Data show that COVID-19 boosters help broaden and strengthen protection against Omicron and other SARS-CoV-2 variants. ACIP reviewed the available safety data following the administration of over 25 million vaccine doses in adolescents.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-17.
COVID Treatment
COVID Remedies
COVID Positive
Given what we currently know about COVID-19 and the Omicron variant, the CDC is shortening the recommended time for isolation. People with COVID should isolate for 5 days and if they are asymptomatic or their symptoms are resolving (without a fever for 24 hours), followed by 5 days of wearing a mask when around others. This change is based on the evidence that the majority of transmission occurs early in the course of illness, generally in the 1-2 days prior to onset of symptoms and the 2-3 days after. All positive results will be reported to the local Health Department and they will contact you with further instructions for contact tracing.
- Increase intake of Vitamin D, Vitamin C, and Zinc
- For adults, take Famotidine 20 mg twice daily
- Increase intake of fluids, rest, and treat symptomatically (ex. Mucinex, Zarbees for Kids [with Zinc, Vit D & C, & Elderberry], nasal decongestants, Ibuprofen, Tylenol)
- Avoid cough suppressants as this can increase risk of pneumonia
COVID Positive
Given what we currently know about COVID-19 and the Omicron variant, the CDC is shortening the recommended time for isolation. People with COVID should isolate for 5 days and if they are asymptomatic or their symptoms are resolving (without a fever for 24 hours), followed by 5 days of wearing a mask when around others. This change is based on the evidence that the majority of transmission occurs early in the course of illness, generally in the 1-2 days prior to onset of symptoms and the 2-3 days after. All positive results will be reported to the local Health Department and they will contact you with further instructions for contact tracing.
Regardless of the situation, anyone who is exposed is recommended to get a COVID test at day 5 after exposure. If symptoms occur, individuals should immediately quarantine until a negative test is confirmed.
For more information about quarantine and isolation, visit the CDC website.
For more information about quarantine and isolation, visit the CDC website.
